ArticleTherapeutic advances in cardiovascular disease

Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome.

Liping Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.